메뉴 건너뛰기




Volumn 9, Issue 6, 2011, Pages

Scientific Opinion on health claims already evaluated (ID 215, 568, 674, 712, 1398, 1633, 1974, 4191, 4192, 4193, 4236, 4335, 4698, 4704) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
[No Author Info available]

Author keywords

already evaluated; constituent; Food; health claims

Indexed keywords


EID: 85047226896     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2011.2203     Document Type: Note
Times cited : (10)

References (13)
  • 1
    • 85016623458 scopus 로고    scopus 로고
    • Scientific Opinion on the substantiation of health claims related to vitamin D and maintenance of bone and teeth (ID 150, 151, 158), absorption and utilisation of calcium and phosphorus and maintenance of normal blood calcium concentrations (ID 152, 157), cell division (ID 153), and thyroid function (ID 156) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    • 1227
    • EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2009a. Scientific Opinion on the substantiation of health claims related to vitamin D and maintenance of bone and teeth (ID 150, 151, 158), absorption and utilisation of calcium and phosphorus and maintenance of normal blood calcium concentrations (ID 152, 157), cell division (ID 153), and thyroid function (ID 156) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 7(9):1227, 19 pp.
    • (2009) EFSA Journal , vol.7 , Issue.9 , pp. 19
  • 2
    • 85078391480 scopus 로고    scopus 로고
    • Scientific Opinion on the substantiation of health claims related to calcium and maintenance of bones and teeth (ID 224, 230, 231, 354, 3099), muscle function and neurotransmission (ID 226, 227, 230, 235), blood coagulation (ID 230, 236), energy-yielding metabolism (ID 234), function of digestive enzymes (ID 355), and maintenance of normal blood pressure (ID 225, 385, 1419) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    • 1210
    • EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2009b. Scientific Opinion on the substantiation of health claims related to calcium and maintenance of bones and teeth (ID 224, 230, 231, 354, 3099), muscle function and neurotransmission (ID 226, 227, 230, 235), blood coagulation (ID 230, 236), energy-yielding metabolism (ID 234), function of digestive enzymes (ID 355), and maintenance of normal blood pressure (ID 225, 385, 1419) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 7(9):1210, 27 pp.
    • (2009) EFSA Journal , vol.7 , Issue.9 , pp. 27
  • 3
    • 85050852524 scopus 로고    scopus 로고
    • Scientific Opinion on the substantiation of health claims related to alpha-linolenic acid and maintenance of normal blood cholesterol concentrations (ID 493) and maintenance of normal blood pressure (ID 625) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    • 1252
    • EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2009c. Scientific Opinion on the substantiation of health claims related to alpha-linolenic acid and maintenance of normal blood cholesterol concentrations (ID 493) and maintenance of normal blood pressure (ID 625) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 7(9):1252, 17 pp.
    • (2009) EFSA Journal , vol.7 , Issue.9 , pp. 17
  • 4
    • 85078381137 scopus 로고    scopus 로고
    • Scientific Opinion on the substantiation of health claims related to lactase enzyme and breaking down lactose (ID 1697, 1818) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    • 1236
    • EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2009d. Scientific Opinion on the substantiation of health claims related to lactase enzyme and breaking down lactose (ID 1697, 1818) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 7(9):1236, 13 pp.
    • (2009) EFSA Journal , vol.7 , Issue.9 , pp. 13
  • 5
    • 85078378678 scopus 로고    scopus 로고
    • Scientific Opinion on the substantiation of health claims related to protein and increase in satiety leading to a reduction in energy intake (ID 414, 616, 730), contribution to the maintenance or achievement of a normal body weight (ID 414, 616, 730), maintenance of normal bone (ID 416) and growth or maintenance of muscle mass (ID 415, 417, 593, 594, 595, 715) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    • 1811
    • EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2010a. Scientific Opinion on the substantiation of health claims related to protein and increase in satiety leading to a reduction in energy intake (ID 414, 616, 730), contribution to the maintenance or achievement of a normal body weight (ID 414, 616, 730), maintenance of normal bone (ID 416) and growth or maintenance of muscle mass (ID 415, 417, 593, 594, 595, 715) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 8(10):1811, 24 pp.
    • (2010) EFSA Journal , vol.8 , Issue.10 , pp. 24
  • 6
    • 84956625438 scopus 로고    scopus 로고
    • Scientific Opinion on the substantiation of health claims related to plant sterols and plant stanols and maintenance of normal blood cholesterol concentrations (ID 549, 550, 567, 713, 1234, 1235, 1466, 1634, 1984, 2909, 3140), and maintenance of normal prostate size and normal urination (ID 714, 1467, 1635) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    • 1813
    • EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2010b. Scientific Opinion on the substantiation of health claims related to plant sterols and plant stanols and maintenance of normal blood cholesterol concentrations (ID 549, 550, 567, 713, 1234, 1235, 1466, 1634, 1984, 2909, 3140), and maintenance of normal prostate size and normal urination (ID 714, 1467, 1635) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 8(10):1813, 22 pp.
    • (2010) EFSA Journal , vol.8 , Issue.10 , pp. 22
  • 7
    • 85078396270 scopus 로고    scopus 로고
    • Scientific Opinion on the substantiation of a health claim related to ethanol-water extract of Caralluma fimbriata (Slimaluma®) and helps to reduce body weight pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    • 1604
    • EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2010c. Scientific Opinion on the substantiation of a health claim related to ethanol-water extract of Caralluma fimbriata (Slimaluma®) and helps to reduce body weight pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal, 8(5):1604, 11 pp.
    • (2010) EFSA Journal , vol.8 , Issue.5 , pp. 11
  • 8
    • 85078396270 scopus 로고    scopus 로고
    • Scientific Opinion on the substantiation of a health claim related to ethanol-water extract of Caralluma fimbriata (Slimaluma®) and helps to control hunger/appetite pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    • 1606
    • EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2010d. Scientific Opinion on the substantiation of a health claim related to ethanol-water extract of Caralluma fimbriata (Slimaluma®) and helps to control hunger/appetite pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal, 8(5):1606, 10 pp.
    • (2010) EFSA Journal , vol.8 , Issue.5 , pp. 10
  • 9
    • 85078396270 scopus 로고    scopus 로고
    • Scientific Opinion on the substantiation of a health claim related to ethanol-water extract of Caralluma fimbriata (Slimaluma®) and helps to reduce waist circumference pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    • 1602
    • EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2010e. Scientific Opinion on the substantiation of a health claim related to ethanol-water extract of Caralluma fimbriata (Slimaluma®) and helps to reduce waist circumference pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal, 8(5):1602, 11 pp.
    • (2010) EFSA Journal , vol.8 , Issue.5 , pp. 11
  • 10
    • 85078386511 scopus 로고    scopus 로고
    • Scientific Opinion on the substantiation of health claims related to pectins and reduction of post-prandial glycaemic responses (ID 786), maintenance of normal blood cholesterol concentrations (ID 818) and increase in satiety leading to a reduction in energy intake (ID 4692) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    • 1747
    • EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2010f. Scientific Opinion on the substantiation of health claims related to pectins and reduction of post-prandial glycaemic responses (ID 786), maintenance of normal blood cholesterol concentrations (ID 818) and increase in satiety leading to a reduction in energy intake (ID 4692) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 8(10):1747, 17 pp.
    • (2010) EFSA Journal , vol.8 , Issue.10 , pp. 17
  • 11
    • 85078388020 scopus 로고    scopus 로고
    • Scientific Opinion on the substantiation of health claims related to chromium and contribution to normal macronutrient metabolism (ID 260, 401, 4665, 4666, 4667), maintenance of normal blood glucose concentrations (ID 262, 4667), contribution to the maintenance or achievement of a normal body weight (ID 339, 4665, 4666), and reduction of tiredness and fatigue (ID 261) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    • 1732
    • EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2010g. Scientific Opinion on the substantiation of health claims related to chromium and contribution to normal macronutrient metabolism (ID 260, 401, 4665, 4666, 4667), maintenance of normal blood glucose concentrations (ID 262, 4667), contribution to the maintenance or achievement of a normal body weight (ID 339, 4665, 4666), and reduction of tiredness and fatigue (ID 261) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 8(10):1732, 23 pp.
    • (2010) EFSA Journal , vol.8 , Issue.10 , pp. 23
  • 12
    • 85078372341 scopus 로고    scopus 로고
    • Scientific Opinion on the substantiation of health claims related to the replacement of mixtures of saturated fatty acids (SFAs) as present in foods or diets with mixtures of monounsaturated fatty acids (MUFAs) and/or mixtures of polyunsaturated fatty acids (PUFAs), and maintenance of normal blood LDL-cholesterol concentrations (ID 621, 1190, 1203, 2906, 2910, 3065) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    • 2069
    • EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2011a. Scientific Opinion on the substantiation of health claims related to the replacement of mixtures of saturated fatty acids (SFAs) as present in foods or diets with mixtures of monounsaturated fatty acids (MUFAs) and/or mixtures of polyunsaturated fatty acids (PUFAs), and maintenance of normal blood LDL-cholesterol concentrations (ID 621, 1190, 1203, 2906, 2910, 3065) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 9(4):2069, 18 pp.
    • (2011) EFSA Journal , vol.9 , Issue.4 , pp. 18
  • 13
    • 85078387685 scopus 로고    scopus 로고
    • Scientific Opinion on the substantiation of health claims related to choline and contribution to normal lipid metabolism (ID 3186), maintenance of normal liver function (ID 1501), contribution to normal homocysteine metabolism (ID 3090), maintenance of normal neurological function (ID 1502), contribution to normal cognitive function (ID 1502), and brain and neurological development (ID 1503) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    • 2056
    • EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2011b. Scientific Opinion on the substantiation of health claims related to choline and contribution to normal lipid metabolism (ID 3186), maintenance of normal liver function (ID 1501), contribution to normal homocysteine metabolism (ID 3090), maintenance of normal neurological function (ID 1502), contribution to normal cognitive function (ID 1502), and brain and neurological development (ID 1503) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 9(4):2056, 23 pp.
    • (2011) EFSA Journal , vol.9 , Issue.4 , pp. 23


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.